|
|
|||
|
||||
OverviewWith the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients. This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology. Full Product DetailsAuthor: Tariq Mughal (FRCP MRCS, Consultant Cancer Physician, Christie Hospital NHS Trust, Manchester, UK)Publisher: Informa Healthcare Imprint: Informa Healthcare ISBN: 9781281801203ISBN 10: 1281801208 Pages: 272 Publication Date: 17 November 2008 Audience: General/trade , General Format: Undefined Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |